<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03913520</url>
  </required_header>
  <id_info>
    <org_study_id>2019/12FEV/072</org_study_id>
    <nct_id>NCT03913520</nct_id>
  </id_info>
  <brief_title>Outcome of Patients With Congenital Heart Disease</brief_title>
  <acronym>OUTCARDIOP</acronym>
  <official_title>Postoperative Outcome of Patients With Congenital Heart Disease Presenting for Non-cardiac Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Advanced surgical and medical healthcare systems have resulted in an increased prevalence of
      children and adults with congenital heart disease in Western countries. These patients often
      necessitate non-cardiac interventions. Previous studies have demonstrated that these patients
      are at increased risk of morbidity and mortality when presenting for non-cardiac
      interventions. The aim of this study is to know the prevalence of patients with congenital
      heart disease presenting for non-cardiac interventions in a tertiary hospital and to
      determine their outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies have shown that children and adults presenting with congenital heart disease
      are at increased risk of morbidity and mortality after non-cardiac interventions. This risk
      depends on the type of pathology, the age of the patient and the experience of the physicians
      in charge of these patients.

      We sought to determine the prevalence of children and adults with congenital heart disease
      presenting for non-cardiac interventions and to investigate their outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence of patients with congenital heart disease presenting for non-cardiac interventions in a single-centre tertiary hospital</measure>
    <time_frame>Intraoperative</time_frame>
    <description>To analyze the exact number of children and adults with congenital heart disease presenting for non-cardiac interventions in a tertiary hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To analyze morbidity after non-cardiac interventions in patients with congenital heart disease</measure>
    <time_frame>30 days</time_frame>
    <description>Morbidity outcome after non-cardiac interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To analyze mortality after non-cardiac interventions in patients with congenital heart disease</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality outcome after non-cardiac interventions</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Congenital Heart Disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Undergoing evaluation at 30 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outcome research</intervention_name>
    <description>patients will undergo an evaluation of their outcome at 30 days postoperatively</description>
    <arm_group_label>Congenital Heart Disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All children and adults with congenital heart disease

        Exclusion Criteria:

          -  Parental or patient refusal

          -  Patients presenting for cardiac interventions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mona MOMENI, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mona MOMENI, MD, PhD</last_name>
    <phone>+3227647029</phone>
    <email>mona.momeni@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MONA MOMENI, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>MONA MOMENI, M.D.; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2019</study_first_posted>
  <last_update_submitted>May 4, 2020</last_update_submitted>
  <last_update_submitted_qc>May 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

